CDKN2A (and adjacent CDKN2B) loss has been previously identified in a small minority of gangliogliomas as well as in other pediatric CNS tumors, such as pleomorphic xanthroastrocytoma (where CDKN2A/B loss is typical) [22, 60, 70]. Here, CDKN2A is linked to central nervous system neoplasm.